Quantum-Si (Quantum-Si) DeferredTaxAndRevenue : $0.00 Mil (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Quantum-Si DeferredTaxAndRevenue?

Deferred Tax And Revenue represents the current portion of obligations, which is a liability that usually would have been paid but is now pas due.

Quantum-Si's current deferred tax and revenue for the quarter that ended in Dec. 2023 was $0.00 Mil.

Quantum-Si DeferredTaxAndRevenue Historical Data

The historical data trend for Quantum-Si's DeferredTaxAndRevenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Quantum-Si DeferredTaxAndRevenue Chart

Quantum-Si Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

DeferredTaxAndRevenue

Quantum-Si Quarterly Data
	Dec19	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
DeferredTaxAndRevenue	Get a 7-Day Free Trial											-	-	-	-	-

Quantum-Si DeferredTaxAndRevenue Related Terms

Thank you for viewing the detailed overview of Quantum-Si's DeferredTaxAndRevenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Quantum-Si (Quantum-Si) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Quantum-Si Inc (NAS:QSI) » Definitions » DeferredTaxAndRevenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

530 Old Whitfield Street, Guilford, CT, USA

Website

https://www.quantum-si.com

Quantum-Si Inc is focused on revolutionizing the growing field of proteomics. The company's suite of technologies is powered by a first-of-its-kind semiconductor chip designed to enable single-molecule next-generation protein sequencing and genomics, and digitize proteomic research in order to advance drug discovery and diagnostics beyond DNA sequencing.

Executives

Amir Jafri	director	C/O QUANTUM-SI INCORPORATED, 29 BUSINESS PARK DR., BRANFORD CT 06405
John P. Kenny	director	3471 RIVER HILLS DRIVE, CINCINNATI OH 45244
Jeffry R. Keyes	officer: Chief Financial Officer	13950 STOWE DRIVE, POWAY CA 92064-8803
Scott Mendel	director	5964 LA PLACE COURT, ADDRESS 2, CARLSBAD CA 92008
Christian Lapointe	officer: General Counsel & Corp. Secr.	C/O QUANTUM-SI INCORPORATED, 530 OLD WHITFIELD STREET, GUILFORD CT 06437
Grace Johnston	officer: Chief Commercial Officer	C/O QUANTUM-SI INCORPORATED, 530 OLD WHITFIELD STREET, GUILFORD CT 06437
Kevin Rakin	director, officer: Chairman and CEO	36 CHURCH LANE, WESTPORT CT 06880
Jeffrey Alan Hawkins	director, officer: Chief Executive Officer	5964 LA PLACE COURT, CARLSBAD CA 92008
Vikram Bajaj	director	600 MONTGOMERY STREET, SUITE 4500, SAN FRANCISCO CA 94111
Jonathan M Rothberg	director, 10 percent owner	C/O BUTTERFLY NETWORK, INC., 530 OLD WHITFIELD ST., GUILFORD CT 06437
Matthew Dyer	officer: Chief Business Officer	C/O QUANTUM-SI INCORPORATED, 530 OLD WHITFIELD STREET, GUILFORD CT 06437
Michael P Mckenna	officer: President and COO	C/O CURAGEN CORP, 555 LONG WHARF DR. 11TH FL., NEW HAVEN CT 06511
Patrick Schneider	officer: President and COO	C/O QUANTUM-SI INCORPORATED, 530 OLD WHITFIELD STREET, GUILFORD CT 06437
John Viii Stark	director, officer: Chief Executive Officer	C/O QUANTUM-SI INCORPORATED, 530 OLD WHITFIELD STREET, GUILFORD CT 06437
2012 Jmr Trust Common Llc	10 percent owner	C/O QUANTUM-SI INCORPORATED, 530 OLD WHITFIELD STREET, GUILFORD CT 06437